Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 7
2018 9
2019 14
2020 13
2021 16
2022 11
2023 12
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for mohammadreza mohebbi n
Search for Mohammadreza Mohebbian instead (1 results)
A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial of adjunctive N-Acetylcysteine for treatment-resistant PTSD.
Kanaan RA, Oliver G, Dharan A, Sendi S, Maier A, Mohebbi M, Ng C, Back SE, Kalivas P, Berk M. Kanaan RA, et al. Among authors: mohebbi m. Psychiatry Res. 2023 Sep;327:115398. doi: 10.1016/j.psychres.2023.115398. Epub 2023 Jul 30. Psychiatry Res. 2023. PMID: 37540942 Free article. Clinical Trial.
BACKGROUND: PTSD may involve oxidative stress, and N-acetylcysteine (NAC) may reduce the impact of oxidative stress in the brain. ...
BACKGROUND: PTSD may involve oxidative stress, and N-acetylcysteine (NAC) may reduce the impact of oxidative stress in the brain. ...
Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
Green JE, Berk M, Mohebbi M, Loughman A, McGuinness AJ, Castle D, Chatterton ML, Perez J, Strandwitz P, Athan E, Hair C, Nierenberg AA, Cryan JF, Jacka F. Green JE, et al. Among authors: mohebbi m. Can J Psychiatry. 2023 May;68(5):315-326. doi: 10.1177/07067437221150508. Epub 2023 Jan 13. Can J Psychiatry. 2023. PMID: 36637229 Free PMC article. Clinical Trial.
METHODS: The study was an 8-week, double-blind, 2:1 parallel group, randomized controlled pilot trial (n = 15) of enema-delivered FMT (n = 10) compared with a placebo enema (n = 5) in adults with moderate-to-severe MDD. ...
METHODS: The study was an 8-week, double-blind, 2:1 parallel group, randomized controlled pilot trial (n = 15) of enema-delivered FMT …
N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial.
McKetin R, Dean OM, Turner A, Kelly PJ, Quinn B, Lubman DI, Dietze P, Carter G, Higgs P, Sinclair B, Reid D, Baker AL, Manning V, Pas NT, Thomas T, Bathish R, Raftery DK, Wrobel A, Saunders L, Arunogiri S, Cordaro F, Hill H, Hall S, Clare PJ, Mohebbi M, Berk M. McKetin R, et al. Among authors: mohebbi m. EClinicalMedicine. 2021 Jul 13;38:101005. doi: 10.1016/j.eclinm.2021.101005. eCollection 2021 Aug. EClinicalMedicine. 2021. PMID: 34308314 Free PMC article.
BACKGROUND: Methamphetamine dependence is a significant global health concern for which there are no approved medications. The cysteine prodrug, N-acetylcysteine (NAC), has been found to ameliorate glutamate dysregulation in addiction, and to reduce craving for methampheta …
BACKGROUND: Methamphetamine dependence is a significant global health concern for which there are no approved medications. The cysteine prod …
A web-based low carbohydrate diet intervention significantly improves glycaemic control in adults with type 2 diabetes: results of the T2Diet Study randomised controlled trial.
Dening J, Mohebbi M, Abbott G, George ES, Ball K, Islam SMS. Dening J, et al. Among authors: mohebbi m. Nutr Diabetes. 2023 Aug 27;13(1):12. doi: 10.1038/s41387-023-00240-8. Nutr Diabetes. 2023. PMID: 37633959 Free PMC article. Clinical Trial.
RESULTS: Ninety-eight participants were enrolled, assigning 49 to each group, with 87 participants (n = 40 intervention; n = 47 control) included in outcome analysis. ...
RESULTS: Ninety-eight participants were enrolled, assigning 49 to each group, with 87 participants (n = 40 intervention; n = 4 …
Identifying aroma-active compounds in coffee-flavored dairy beverages.
Mahmud MMC, Keast R, Mohebbi M, Shellie RA. Mahmud MMC, et al. Among authors: mohebbi m. J Food Sci. 2022 Mar;87(3):982-997. doi: 10.1111/1750-3841.16071. Epub 2022 Feb 17. J Food Sci. 2022. PMID: 35175625 Free PMC article.
Nine coffee-flavored dairy beverages were formulated: low fat-low coffee; medium fat-low coffee; high fat-low coffee; low fat-medium coffee; medium fat-medium coffee; high fat-medium coffee; low fat-high coffee; medium fat-high coffee; and high fat-high coffee. Regular coffee con …
Nine coffee-flavored dairy beverages were formulated: low fat-low coffee; medium fat-low coffee; high fat-low coffee; low fat-medium coffee; …
The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial.
Russell SE, Skvarc DR, Mohebbi M, Camfield D, Byrne LK, Turner A, Ashton MM, Berk M, Dodd S, Malhi GS, Cotton SM, Bush AI, Dean OM. Russell SE, et al. Among authors: mohebbi m. Clin Psychopharmacol Neurosci. 2023 May 30;21(2):320-331. doi: 10.9758/cpn.2023.21.2.320. Clin Psychopharmacol Neurosci. 2023. PMID: 37119225 Free PMC article.
OBJECTIVE: N-acetylcysteine (NAC) is a novel therapeutic agent with multiple mechanisms of action in the central nervous system and a favourable side effect profile. ...
OBJECTIVE: N-acetylcysteine (NAC) is a novel therapeutic agent with multiple mechanisms of action in the central nervous system and a …
Falls in community-dwelling women with bipolar disorder: a case-control study.
Stuart AL, Pasco JA, Berk M, Quirk SE, Koivumaa-Honkanen H, Honkanen R, Mohebbi M, Williams LJ. Stuart AL, et al. Among authors: mohebbi m. BMC Psychiatry. 2022 Sep 20;22(1):620. doi: 10.1186/s12888-022-04258-7. BMC Psychiatry. 2022. PMID: 36127652 Free PMC article.
Thus, we aimed to investigate falls risk in community-dwelling women diagnosed with BD. METHODS: Women with BD (cases, n = 119) were recruited from health care settings located in southeast Victoria, Australia. Age-matched controls (n = 357, ratio 3:1) without BD we …
Thus, we aimed to investigate falls risk in community-dwelling women diagnosed with BD. METHODS: Women with BD (cases, n = 119) were …
Understanding perceived social support among women with personality disorder clusters.
Kavanagh BE, Mohebbi M, Quirk SE, Pasco JA, Williams LJ. Kavanagh BE, et al. Among authors: mohebbi m. Australas Psychiatry. 2021 Dec;29(6):595-599. doi: 10.1177/10398562211029948. Epub 2021 Aug 24. Australas Psychiatry. 2021. PMID: 34428985
We also investigated potential differences in PSS according to PD clusters (clusters A, B, C). METHODS: Women (n = 718) from the Geelong Osteoporosis Study completed the Multidimensional Scale of Perceived Social Support (MPSS) and Structured Clinical Interview for DSM-IV …
We also investigated potential differences in PSS according to PD clusters (clusters A, B, C). METHODS: Women (n = 718) from the Geel …
A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smoking.
Arancini L, Mohebbi M, Berk M, Dean OM, Bortolasci CC, Spolding B, Zazula R, Dodd S. Arancini L, et al. Among authors: mohebbi m. Eur Neuropsychopharmacol. 2021 Dec;53:120-126. doi: 10.1016/j.euroneuro.2021.10.002. Epub 2021 Oct 31. Eur Neuropsychopharmacol. 2021. PMID: 34757312 Clinical Trial.
Novel therapies are required to assist this group with cessation. N-acetylcysteine (NAC) is a nutraceutical supplement that has shown efficacy compared to placebo in previous pilot studies for assisting smokers to quit or reduce their consumption of cigarettes. A double-bl …
Novel therapies are required to assist this group with cessation. N-acetylcysteine (NAC) is a nutraceutical supplement that has shown …
Osteoporosis medication use among Australian women over two decades.
Stuart AL, Pasco JA, Mohebbi M, Kotowicz MA, Holloway-Kew KL, Hosking SM, Williams LJ. Stuart AL, et al. Among authors: mohebbi m. Arch Osteoporos. 2020 May 6;15(1):67. doi: 10.1007/s11657-019-0661-7. Arch Osteoporos. 2020. PMID: 32372368
Women at high risk of fracture were identified by BMD (time-1, n = 231 (28.1%); time-2, n = 92 (16.0%); time-3, n = 51 (9.7%)) and FRAX criteria (time-1, n = 272 (33.1%); time-2, n = 105 (18.3%); time-3, n = 100 (19.0%)). ...
Women at high risk of fracture were identified by BMD (time-1, n = 231 (28.1%); time-2, n = 92 (16.0%); time-3, n = 51 …
74 results